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Mast cell neoplasia in dogs can occur in two different forms: common as cutaneous 
tumor, or less common as a systemic form of  neoplastic mast cell proliferation – systemic 
mastocytosis. The aim of  this study was to compare the histological and cytological 
features, KIT receptor expression and presence of  c-KIT proto-oncogene mutations in 
neoplastic cells of  dogs with canine cutaneous mast cell tumor (CMCT) and systemic 
mastocytosis. Microscopical examination of  the cytological smears obtained from all 
selected dogs revealed that cellular specimens were constituted mostly of  round cells 
with a central nuclei and fi ne to coarse purple cytoplasmic granules. Histopathological 
examination of  skin samples of  dogs with CMCT and a dog with systemic mastocytosis 
showed proliferation of  the neoplastic mast cells in the superfi cial and/or deep dermis. 
Similar fi ndings were observed in tissue samples derived from lymph nodes, spleen, 
liver, myocardium and kidneys of  a dog with systemic mastocytosis. Three dogs with 
high grade CMCT as well as one dog with systemic mastocytosis showed cytoplasmic 
CD117 expression, while 3 dogs with low grade CMCT, had membranous expression 
of  CD117. Based on our study, histological features and cytoplasmic CD117 expression 
in neoplastic cells of  dogs with systemic mastocytosis are similar to those in dogs with 
high grade CMCTs. Nevertheless, mutations of  c-KIT proto-oncogene were not found 
in tumor samples either from dogs with CMCT or dog with systemic mastocytosis.
Key words: dog, systemic mastocytosis, cutaneous mast cell tumor, KIT receptor 
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INTRODUCTION
Mast cell disorders have been documented both in humans and animals and are defi ned 
as an abnormal accumulation of  mast cells in one or more organs. Neoplastic disorders 
of  mast cells are rare and almost always benign in humans [1] comparing to animals in 
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which they represent ubiquitous neoplasms with species variation of  localization and 
biological behavior. They are common neoplasms in dogs, most often seen in older 
animals. Boxers, Pugs, Boston terriers, Weimaraners, Labrador retrievers and Golden 
retrievers have a high propensity for cutaneous mast cell tumors (CMCT) [2]. Systemic 
mastocytosis (systemic mast cell neoplasia) is a term used to describe the proliferation 
and invasion of  neoplastic mast cells in several tissues, such as subcutis, lymph nodes, 
internal organs and bone marrow, with or without concurrent mast cell leukemia. This 
type of  mast cell neoplasia is less frequent comparing to cutaneous mast cell neoplasia, 
which represents one of  the commonest skin tumors in dogs [3]. Mast cell tumors 
were most often graded histologically according to the grading system described by 
Patnaik et al. [4], and nowadays more often by the grading system proposed by Kiupel 
et al. [5]. Patnaik grading system is based on level of  differentiation, cellularity, cellular 
morphology, mitotic index and tissue reaction and it has been widely used [6].
According to the Kiupel grading system, high-grade MCTs include neoplasms with at 
least one of  the following features: at least 7 mitotic fi gures in 10 high power fi elds 
(hpf); at least 3 multinucleated cells in 10 hpf; at least 3 bizarre nuclei in 10 hpf; or at 
least 10% karyomegalic neoplastic cells. All other tumors are considered low grade [5].
Recently, the KIT receptor expression is considered to be the most useful predictive 
marker [7,8]. Non-neoplastic mast cells as well as some neoplastic mast cells have only 
membranous KIT localization while in many neoplastic mast cells KIT accumulates 
in the cytoplasm [8-10]. The correlation between the expression of  the KIT receptor 
and the histologic grade of  CMCTs seems to be very important [11,12] and some 
authors believe that there is a correlation between the degree of  CMCT differentiation 
and KIT expression pattern [9]. A signifi cant association between the aberrant KIT 
localization and presence of  c-KIT proto-oncogene mutations was identifi ed in dogs 
with CMCTs. However, mutations were not present in all CMCT samples with aberrant 
KIT expression [13].
The aim of  this study was to compare the histological and cytological features, KIT 
receptor expression and presence of  c-KIT proto-oncogene mutations in neoplastic 
cells of  dogs with CMCT and systemic mastocytosis.
MATERIAL AND METHODS
Animals
A 12-year-old intact female mixed breed dog with multiple cutaneous masses and six 
dogs of  different breeds, sex and age with single cutaneous mast cell tumor were 
selected from the Faculty of  Veterinary Medicine, University of  Belgrade (Table 1). 
Skin without dermal lesions sampled at necropsy from 3 adult dogs was used as the 
control.
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DNA Isolate
A known dog DNA isolate containing the c-KIT mutation was used as the positive 
control. DNA isolate originates from the College of  Veterinary Medicine, Department 
of  Pathobiology and Diagnostic Investigation from the Michigan State University, 
USA.
Clinical examination
Complete clinical evaluation (anamnesis, physical and dermatological examination) was 
done. Informed consent was obtained from all the dog owners as well as anamnestic 
data. An ultrasonographic evaluation of  the abdomen was performed in all animals 
included in this study.
Haematology
Complete blood analysis was performed on the blood sample with EDTA from the dog 
with systemic mastocytosis. Analysis was conducted on the ProCyte DX Hematology 
Analyzer (IDEXX Laboratories, USA). Biochemical analyses of  blood serum were 
performed using the VetTest Chemistry Analyzer (IDEXX Laboratories, USA).
Fine needle aspiration
Fine needle aspiration biopsy for each patient was preliminarily performed on the skin 
nodule using a 22 gauge needle. Cytological smears were made, dried and stained with 
Diff  Quick (Hemacolor® Merck) and Toluidine blue staining methods.
Histopathology
Skin samples obtained with punch biopsy as well as skin or other tissue samples 
obtained by surgical removal or on necropsy were fi xed in 10% buffered formalin for 
48 hours. After standard processing in an automated tissue processor, tissue samples 
were embedded in paraffi n blocks. Initial diagnosis and grading of  tumors had been 
undertaken on hematoxylin and eosin (HE) stained sections. Toluidine blue staining 
Table 1. Breed, gender, age and type of  examined dogs with MCT
Dog 
No.
Breed Gender Age, years Type of  MCT
1. Mixed breed female 12 Systemic mastocytosis
2. German boxer male 8.5 CMCT
3. Golden retriever female 8 CMCT
4. Golden retriever male 11 CMCT
5. Maltese female 8 CMCT
6. American bulldog male 10 CMCT
7. Golden retriever female 11 CMCT
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(TB) was performed on all sections as the confi rmative histochemical method. Mast 
cell tumor histopathological features, such as number of  mitotic fi gures, presence of  
multinucleated cells, bizarre nuclei and karyomegaly were evaluated on the HE stained 
sections. Each parameter was observed on 10 high power (400x) fi elds (hpf).
Immunohistochemical staining
Formalin fi xed and paraffi n embedded tissue samples were cut to a 4 μm sections and 
deparaffi nized in xylene, rehydrated in graded alcohol and rinsed in distilled water. 
Immunohistochemical methods were performed with CD117 polyclonal rabbit anti-
human antibody (DAKO, A4502). Antigen retrival was achieved by heating with buffer 
citrate pH 6.0 for 20 minutes [14]. Endogenous peroxidase activity was blocked by 
treating slides with hydrogen peroxide in methanol (3%) for 15 minutes. Nonspecifi c 
binding of  secondary antibodies was minimized by incubation with 50% normal goat 
serum in PBS for 20 minutes. After antigen retrieval and inactivation of  endogenous 
peroxidase, the sections were incubated with primary antibody at dilution 1 : 400 in 
PBS for 1 hour in a moist chamber at 22±3oC. A streptavidin–immunoperoxidase 
staining procedure was used for immunolabeling. The immunoreaction was visualized 
with DAB+ (3,3’-diaminobenzidine tetrahydrochloride, DAKO, K3468). Sections were 
counterstained with Mayer’s hematoxylin. Aqueous medium glycergel (DAKO, C563) 
was used on the stained sections for mounting. Finally, the CD117 positive cells were 
observed under the light microscope in hpf. Skin sections not treated with the primary 
antibody were used as the  negative control. The positive immunohistochemical 
control included the already confi rmed canine MCT. 
Polymerase chain reaction (PCR)
DNA was extracted from the paraffi n blocks using the commercial set „KAPA 
Express Extract Kit” (Cat. No KK7152, Kapa Biosystems, Cape Town, South Africa) 
according to the manufacturer’s instructions. PCR amplifi cation was performed as 
previously described by Jones et al. [15]. A known dog DNA isolate containing c-KIT 
mutation was used as the positive control.
RESULTS
Clinical fi ndings in dog with systemic mastocytosis
Past medical history did not include any major illnesses and vaccination was routinely 
performed. One month after surgical removal of  a 2 cm wide red hairless lump from 
the tarsal region of  the hind right leg, similar skin changes, fi rst in the head and neck 
region, and later in other body regions, particularly on the ventral part of  the abdomen 
and thorax appeared. These changes were extremely prone to hemorrhages. At that 
time the dog was treated with local and systemic antibiotics and corticosteroids which 
improved the condition. After exclusion of  the corticosteroids the condition got 
Acta Veterinaria-Beograd 2015, 65 (2), 226-237
230
worse. Routinely performed skin swabs and scarifi cation did not reveal any pathogen 
microbes or skin parasites. After constant antibiotic therapy and local treatment of  the 
lesions, the condition did not improve. 
Physical examination revealed fairly normal levels of  several parameters: body 
temperature of  38.2ºC, heart rate 96, respiration rate 32 and capillary fi lling time 2 
seconds. All visible mucosal surfaces were hyperemic and a mild swelling of  nasal 
and oral mucosa was evident. Whitish vaginal discharge was also present. The dog 
was oriented with no signs of  aggression. Peripheral lymph nodes were palpable, the 
size of  submandibular lymph node was 1x2 cm, and the  prescapular, axillary, inguinal 
and popliteal lymph nodes were 1x1 cm large. Lung auscultation revealed a sharp 
vesicular respiration sound, and heart auscultation revealed a rhythmic pace without 
heart murmurs. On the entire body surface (head, neck, thorax and abdomen) nodules 
and plaques of  different size were present, and a number of  them were hemorrhagic 
(Fig. 1a). Also on the ventral part of  the thorax and abdomen in the mammary region 
one large hard fused plaque was palpable. After hair clipping these skin changes were 
extremely erythematous and prone to hemorrhage.  
Blood testing showed mild anemia (erithrocytes 4.05 x1012/l, Hg 86g/l, HT 25.86%) 
while other erythrocytic indices were in the physiological range for an adult dog 
(MCV 64fl , MCH 21.2pg, MCHC 332g/l, RDW 23.7%). Also a low platelet count was 
recorded (platelets 112 x109/l). White blood count was within the physiological range 
(total WBC 5.74x109/l), while the leukocyte formula showed distinctive lymphocytosis 
(lymphocytes 0.1 x109/l). 
Biochemical analysis of  blood serum revealed that values of  all parameters were in the 
physiological levels characteristic for adult dogs.
Homogenous enlargement of  the spleen, enlargement of  the abdominal lymph nodes, 
presence of  anechogenic accumulation of  liquid content in the left uterine horn and 
echogenic accumulation in the region of  the mammary complexes were noticed 
ultrasonographically. 
Cytological fi ndings
Microscopical examination of  the cytological smears obtained from all selected 
dogs (one with systemic mastocytosis and six with CMCT) revealed that the cellular 
specimen constituted mostly of  round cells with central nuclei and fi ne to coarse purple 
cytoplasmic granules. A large number of  eosinophils and degenerated neutrophils 
were also present in the cytological smears. 
Macroscopic changes
On necropsy of  the dog with systemic mastocytosis, multiple nodules were observed 
on various regions of  the skin and subcutis. Most of  those nodules were hyperemic 
and often with hemorrhages. Peripheral, abdominal and mesenteric lymph nodes were 
enlarged, and marked swellings of  the subcutis on head, neck and mammary region 
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were noticed. Nodules of  different size were also observed on the myocardium. The 
spleen was diffusely enlarged (Fig. 1b) and the liver and kidneys were enlarged, pale and 
fragile. The lungs were edematous and hyperemic. Multiple ulcerations were noticed 
on the pyloric region of  the stomach. The uterus was enlarged and fi lled with pus. 
Skin nodules from all dogs included in this study, as well as other tissue samples from 
the dog with suspected systemic mastocytosis, were collected for  histopathology. 
Histopathological and immunohistochemical fi ndings
Histopathological examination of  skin samples of  dogs with CMCT and of  the 
dog with systemic mastocytosis showed proliferation of  neoplastic mast cells in the 
superfi cial and/or deep dermis. Similar fi ndings were observed in tissue samples 
derived from lymph nodes, spleen, liver, myocardium and kidneys of  the dog with 
systemic mastocytosis. These cells were round to polygonal with a round central 
to slightly eccentric nuclei, sometimes with several nuclei. Pale pink cytoplasm was 
fi lled with light gray/bluish granules in HE stained samples, or purple granules in 
TB stained samples. Mitotic fi gures were also observed. According to these facts  the 
dog was diagnosed with systemic mast cell neoplasia, a mast cell tumor of   high grade 
malignancy (grade III Patnaik system, or high grade Kiupel system) (Fig. 2a, b, c). Out 
of  6 dogs with cutaneous mast cell tumor, 3 dogs had low grade malignancy tumors 
(Fig. 3a) and 3 dogs had high grade malignancy tumors (Fig. 4a) according to Kiupel 
grading system.
Three dogs with high grade CMCT as well as one dog with systemic mastocytosis 
showed both membranous and cytoplasmic CD117 expression (Fig. 2d, 4b), while 
another 3 dogs with low grade CMCT, had only the membranous expression of  CD117 
(Fig. 3b). The presence of  two bands of  ~191 bp and of  ~250bp, characteristic for the 
samples with the mutation, was not detected in any of  the tested CMCT samples. The 
lack of  two bands indicates the absence of  c-KIT mutations in dogs with CMCTs as 
well as in the dog with systemic mastocytosis.
Figure 1. Macroscopic changes of  the skin and spleen of  the dog with systemic mastocytosis: 
a) Neoplastic nodules on the skin; b) Enlarged spleen
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Figure 2. Microscopic and immunohistochemical changes in the visceral organs and subcutis 
of  the dog with systemic mastocytosis: a) Tumor cells in the spleen, HE. Insert: Cytoplasmic 
granules in the mast cells, TB; b) Tumor cells in the lymph node, HE. Insert: Cytoplasmic 
granules in the mast cells, TB; c) Tumor cells in the liver, HE. Insert: Cytoplasmic granules in 
the mast cells, TB; d) Cytoplasmic KIT-staining pattern in tumor cells of  the subcutis, CD117, 
LSAB2.
Figure 3. Microscopic and immunohistochemical changes in the dog skin with low grade mast 
cell tumor: a) Tumor cells are loosely arranged and separated by collagen bundles, HE. Insert: 
Cytoplasmic granules in the mast cells, TB; b) Membranous KIT-staining pattern, CD117, 
LSAB2
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DISCUSSION 
In domestic animals mast cell neoplasia manifests basically in two forms, as a 
cutaneous neoplasia in the skin and subcutis, or as a systemic mast cell neoplasia 
(systemic mastocytosis), i.e. the form in which neoplastic mast cells invade 
different internal organs. The cutaneous form is common in older dogs with breed 
predisposition of  Boxers, Pugs, Boston terriers, Weimaraners, Labrador retrievers 
and Golden retrievers [2,16] and the second, systemic form is more frequent in cats, 
but it can also occur in dogs. However, this systemic form can be associated with 
concurrent mast cell leukemia [17]. In some cases mastocytemia can occur in dogs 
with the cutaneous form, but more often it occurs in dogs with the systemic form 
of  mast cell neoplasia [17,18]. Macroscopic examination of  the dog with systemic 
mastocytosis revealed multiple nodules on various regions of  the skin and subcutis, 
often hyperemic and with hemorrhages. Beside fi ndings on the skin and subcutis, 
generalized lymphadenopathy, diffuse enlargement of  the spleen, liver and kidneys 
as well as nodules on the myocardium were observed as reported previously [18,19]. 
However, fi ndings of  neoplastic mast cells in other organs (such as lymph nodes, 
liver, spleen, myocardium and kidneys), with or without concurrent mastocytemia, 
is characteristic for systemic mastocytosis. Different clinical signs and paraneoplastic 
syndrome can occur as a consequence of  releasing bioactive substances (histamine, 
heparin, enzymes, prostaglandins, hemotactic factor for eosinophiles etc.) from the 
granules of  the mast cells [20,21]. These signs can include hemorrhagic diathesis, tissue 
erythema and/or oedema, allergic reactions, anorexia, and gastrointestinal ulceration 
(especially gastric) followed by haematemesis and diarrhea as well as abdominal pain 
[18,22]. Subsequently, multiple gastric ulcerations were present in the dog with systemic 
mastocytosis in our study. This type of  lesion occurs as a consequence of  constant 
stimulation of  H2 receptors of  parietal cells in the gastric mucosa by a high level of  
histamine released from the cytoplasmic granules of  mast cells [23,24].
Figure 4. Microscopic and immunohistochemical changes in the dog skin with high grade mast 
cell tumor: a) Pleomorphic low granulated cells with mitotic fi gures, HE. Insert: Degranulated 
mast cells, TB; b) Cytoplasmic KIT-staining pattern, CD117, LSAB2
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Usually, suspicion of  mast cell tumor is made, as in this case, based on clinical signs, 
and especially on the characteristic appearance of  mast cells on the Diff  Quick stained 
cytological smears obtained from skin nodules [25]. Nevertheless, defi nitive diagnosis 
of  the mast cell tumor is based on the histopathological examination of  tissue samples 
of  the skin and different organs as was observed in the dog with systemic mastocytosis 
from our study. All neoplastic cells showed signs of  marked polymorphism. Based 
on our results, in all three cases of  well differentiated CMCTs, the prominent 
fi ndings were: round and monomorphic mast cells arranged in rows or small groups, 
separated by collagen fi bers, the nuclei were round with condensed chromatin and 
intracytoplasmic granules were evident. Mitotic cells were absent or rarely present and 
eosinophilic granulocytes were observed in the neoplastic tissue. On the other hand, 
the other three dogs had less differentiated mast cell tumors (grade III Patnaik system, 
or high grade Kiupel system) that showed a high degree of  cellular pleomorphism. 
The neoplastic, often multinucleated cells were arranged in closely packed sheets. The 
nuclei were large, irregularly shaped and intracytoplasmic granules were fewer. In order 
to differentiate mast cell tumors from other round cell tumors, additional staining with 
TB provides accurate diagnosis due to the fact that cytoplasmic granules of  mast cells 
stain purple [26,27]. 
Nonneoplastic mast cells expressed only membranous KIT staining pattern, whereas 
CMCTs histologically graded as II or III according to Patnaik et al. (or high grade 
malignancy according Kiupel system) predominantely express KIT in their cytoplasm 
[9,11]. Both in the case of  the dog with systemic mastocytosis and dogs with CMCTs 
of  high grade malignancy the cytoplasmic KIT staining pattern was observed. 
However, dogs with CMCTs of  low grade malignancy had only the  membranous KIT 
staining pattern. Despite the cytoplasmic KIT staining patterns are being considered 
as characteristic of  higher grade malignancy CMCTs [9,12] they could just refl ect an 
alteration in biological behavior of  mast cells instead of  indicating a histopathological 
grade [28].  
As in our case, systemic distribution of  mast cell tumors is usually connected with the 
presence of  cutaneous nodules, because it is in most cases secondary to cutaneous 
tumor [29]. Nevertheless, there are described cases of  systemic mastocytosis without 
the presence of  primary cutaneous lesion [30,31].
Based on our study, histological features and cytoplasmic CD117 expression in 
neoplastic cells of  dogs with systemic mastocytosis are similar to those in dogs with 
high grade CMCTs. Nevertheless, mutations of  c-KIT proto-oncogene were not found 
in tumor samples either from dogs with CMCT or dog with systemic mastocytosis.
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MORFOLOŠKE KARAKTERISTIKE I EKSPRESIJA KIT 
RECEPTORA KOD KUTANIH MASTOCITOMA I SISTEMSKE 
MASTOCITOZE PASA
MARINKOVIĆ Darko, MILČIĆ-MATIĆ Natalija, JOVANOVIĆ Milan, VUČIĆEVIĆ 
Ivana, NEŠIĆ Slađan, ANIČIĆ Milan, ALEKSIĆ-KOVAČEVIĆ Sanja
Neoplazme poreklom od mastocita mogu da se jave u dva različita oblika: uobičajeno 
kao kožni tumori – kutani mastocitomi ili ređe kao sistemska forma neoplastične 
proliferacije mastocita – sistemska mastocitoza. Svrha ovog istraživanja je da se 
uporede histološke i citološke karakteristike, ekspresija KIT receptora i prisustvo 
mutacija c-KIT proto-onkogena u neoplastičnim ćelijama kod pasa sa kutanim 
mastocitomima i sistemskom mastocitozom. Mikroskopskim pregledom citoloških 
razmaza svih ispitanih pasa utvrđeno je da se ćelijska populacija sastoji uglavnom od 
okruglih ćelija koje imaju centralno postavljeno jedro i sitne ljubičaste citoplazmatske 
granule. Histopatološkim pregledom uzoraka kože pasa sa kutanim mastocitomima i 
sistemskom mastocitozom zapaženo je umnožavanje mastocita u površinskom i/ili 
dubokom dermisu. Sličan nalaz uočen je i u isečcima tkiva limfnih čvorova, slezine, 
jetre, miokarda i bubrega psa sa sistemskom mastocitozom. Kod tri psa sa kutanim 
mastocitomima visokog stepena maligniteta, kao i kod psa sa sistemskom mastocitozom 
zapažena je citoplazmatska ekspresija CD117, dok je kod tri psa sa kutanim 
mastocitomima niskog stepena maligniteta uočena membranska ekspresija CD117. Na 
osnovu našeg istraživanja, histološke karakteristike i citoplazmatska ekspresija CD117 
na neoplastičnim ćelijama su slične kod pasa sa sistemskom mastocitozom i pasa sa 
kutanim mastocitomima visokog stepena maligniteta. I pored toga, mutacije c-KIT 
proto-onkogena nisu uočene ni kod pasa sa kutanim mastocitomima, ni kod psa sa 
sistemskom mastocitozom.
